KLAC

KLA is a critical “picks-and-shovels” supplier to leading-edge and advanced packaging, with a strong moat in process control (inspection/metrology) where shrinking nodes and tighter yields make its tools increasingly non-discretionary. The demand backdrop remains structurally supported by AI-driven compute builds and the industry’s shift to more complex process steps, which tends to raise KLA’s content per wafer. A recent Newport, Wales R&D/manufacturing expansion should help sustain technology leadership and improve responsiveness to European customers, though it also raises execution and cost-control expectations.

Financially, web-sourced coverage is uneven, but KLA reported fiscal Q1’26 (ended Sep. 30, 2025) revenue of $3.21B and GAAP EPS of $8.47, and fiscal Q2’26 (ended Dec. 31, 2025) EPS of $8.85 (non-provider source) with total revenue cited at $3.30B in the earnings release. Liquidity appears solid: the Dec. 31, 2025 10-Q shows $5.21B of cash/cash equivalents/marketable securities plus $1.50B revolver availability. Capital returns remain a key part of the equity story, with an annual dividend cited around $7.60/share (yield roughly ~0.4%–0.5%), and recent headlines pointing to a large, newly authorized buyback and a sizable dividend step-up (details vary by source, so treat as directional).

Over the next 12 months, the bull case is continued WFE outperformance as foundries/logic prioritize leading-edge and as inspection intensity rises in advanced packaging; Investor Day targets (2030 revenue $26B ± $2.5B and 45%–47% operating margins) reinforce management’s confidence in longer-cycle earnings power. Near-term catalysts include the April 29, 2026 fiscal Q3’26 print/guidance and any incremental clarity on China export controls and customer spending concentration. Key risks are a WFE air pocket (especially memory) and tighter trade restrictions that reduce tool and services attach in China, pressuring growth and mix.

Recommendation: HOLD. KLA is a high-quality compounder with strong structural demand drivers and robust liquidity/capital returns, but the stock’s mega-cap valuation and elevated cyclicality (beta ~1.44) make the next leg higher more dependent on sustained high-teens revenue growth and clean guidance through FY2026.